Form 4: Amgen EVP Esteban Santos Reports Stock Disposition

Amgen EVP of Operations Esteban Santos reported the disposition of 1,338 shares of common stock to cover tax obligations.

Summary

• Esteban Santos, EVP of Operations at Amgen, disposed of a total of 1,338 shares of common stock on May 2, 2026.
• The shares were disposed of at a price of $329.82 per share.
• The transaction was executed to satisfy tax withholding obligations related to the vesting of equity awards.
• Following these transactions, the reporting person maintains direct ownership of 81,066 shares and indirect ownership of 909.9906 shares via a 401(k) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a discretionary sale of shares.

Positives

• The reporting person maintains a significant equity stake of 81,066 shares, indicating continued alignment with shareholder interests.

Negatives

• The filing reflects a reduction in direct share ownership, though this is standard for tax withholding purposes.

Risks

• None identified; this is a routine administrative transaction.

Future Outlook

Not applicable; this is a retrospective report of an insider transaction.

Industry Context

StockSavvy.ai notes that routine Form 4 filings regarding tax withholding upon the vesting of equity awards are standard practice for senior executives in the biotechnology sector and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for executive compensation and tax compliance observed at major pharmaceutical firms like Pfizer, Gilead, and AbbVie.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine tax-related equity adjustment.

Key Dates

Keywords

Amgen, AMGN, Insider Trading, Form 4, Equity Compensation, Executive Ownership